pharma · Hereditary Angioedema · Influenza · BCRX
Biocryst
Biocryst clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- München, DE
- Founded
- 1986
- Employees
- 6
- Programs
- 37
- Drugs
- 17
- Patents
- 72
Biocryst projects
18 ClinicalTrials.gov programs sponsored by Biocryst.
Biocryst has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BCX-1777
Biocryst
Leukemia, Lymphocytic
1 trial -
BCX1777-Tio-05-202
Biocryst
Leukemia
1 trial -
BCX7353
Biocryst
Hereditary Angioedema (HAE)
2 trials -
BCX9930
Biocryst
Paroxysmal Nocturnal Hemoglobinuria
3 trials -
BCX9930
Biocryst
Complement 3 Glomerulopathy
1 trial -
Eculizumab
Biocryst
Paroxysmal Nocturnal Hemoglobinuria (PNH)
1 trial -
Forodesine 200 mg
Biocryst
Cutaneous T-cell Lymphoma (CTCL),
1 trial -
Peramivir
Biocryst
Acute, Uncomplicated Human Influenza
1 trial -
Peramivir 150 mg
Biocryst
Influenza
1 trial -
Peramivir 200 mg
Biocryst
Influenza
1 trial -
Placebo
Biocryst
Paroxysmal Nocturnal Hemoglobinuria (PNH)
1 trial -
Placebo
Biocryst
Gout
3 trials -
forodesine HCl
Biocryst
Chronic Lymphocytic Leukemia (CLL)
1 trial -
forodesine hydrochloride
Biocryst
Lymphoma
2 trials -
forodesine hydrochloride (BCX-1777)
Biocryst
Leukemia, T-Cell
1 trial -
forodesine hydrochloride (BCX-1777)
Biocryst
B-cell Acute Lymphoblastic Leukemia
1 trial -
forodesine hydrochloride (BCX-1777)
Biocryst
Leukemia, Lymphocytic, Chronic
1 trial -
ulodesine
Biocryst
Gout
1 trial
Frequently asked questions
How many clinical projects does Biocryst have?
18 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.